Search - tctmd.com

Displaying 161 - 180 of 199

Sort: Relevancy | Date

Presentation NY Valves 2025

Transcatheter Mitral Valve Replacement in Atrial and Ventricular Secondary Mitral Regurgitation: Insights From the CHOICE-MI Registry

Presenter: Philipp von Stein

June 25, 2025

Presentation NY Valves 2025

Advancing Risk Stratification in Tricuspid Regurgitation: Incremental Prognostic Value of Effective RVEF on CMR

Presenter: Edmund Naami

June 25, 2025

Presentation NY Valves 2025

Performance of Atrial-fixation TMVR in Patients With Mitral Regurgitation (MR) and Mitral Annular Calcification (MAC)

Presenter: Paul Sorajja

June 25, 2025

Presentation NY Valves 2025

Use of JenaValve in a Young Female With Severe Aortic Regurgitation and Takayasu Arteritis

Presenter: Ankit Gauba

June 25, 2025

Presentation NY Valves 2025

Rare Case of Acute Severe Mitral Regurgitation Following Transcatheter Aortic Valve Implantation (TAVI)

Presenter: Ho On Alston Conrad Chiu

June 25, 2025

Presentation NY Valves 2025

Successful Acute Valve-in-Valve Implantation Using Evolut FX Transcatheter Valve in a Failed Non-Calcified Stentless Subcoronary Toronto (SJM) Valve With Severe Aortic Regurgitation

Presenter: Virna Liza Sales

June 25, 2025

News Daily News

‘Sobering’ Adverse Event Rate With Evoque Seen in Real-world Use

Yael L. Maxwell

June 18, 2025

News Daily News

Valve Thrombosis in TTVR Not Uncommon: Meta-analysis

Caitlin E. Cox

June 17, 2025

News Daily News

Tendyne Approved in US for High-risk Patients With Mitral Valve Disease

Michael O'Riordan

May 28, 2025

News Conference News EuroPCR 2025

Myval Noninferior to Other THVs at 1 Year, but Questions Persist

L.A. McKeown

May 21, 2025

News Daily News

Procedural Volumes Matter for VT Ablation

Todd Neale

May 12, 2025

News Conference News SCAI 2025

BATMAN Signals New Way to Prevent LVOT Obstruction in High-Risk TMVR Patients

L.A. McKeown

May 07, 2025

News Conference News HRS 2025

Pairing CIED Lead Extraction With Tricuspid Interventions Appears Safe

Todd Neale

April 28, 2025

News Daily News

LuX-Valve TTVR Device Provides Favorable 1-Year Results

Yael L. Maxwell

April 24, 2025

News Daily News

COMPARE-TAVI 1: Myval Performs Well Against Sapien at 1 Year

Todd Neale

April 11, 2025

News Featured Fellow

Aditya Mehta, MBBS

Yael L. Maxwell

April 10, 2025

News Daily News

CMS Releases Proposed Decision Memo for Tricuspid TEER

L.A. McKeown

April 04, 2025

News Conference News ACC 2025

By 2 Years, Tricuspid TEER Reduces Hospitalizations for HF: TRILUMINATE

Michael O'Riordan

March 31, 2025

News Conference News ACC 2025

Evolut Low Risk Trial: TAVI Holds Up to Surgery at 5 Years

L.A. McKeown

March 30, 2025

News Conference News ACC 2025

More ALIGN-AR Data Bolster Potential for a Dedicated AR Device

Yael L. Maxwell

March 30, 2025

Advertisement

Transcatheter Mitral Valve Replacement in Atrial and Ventricular Secondary Mitral Regurgitation: Insights From the CHOICE-MI Registry

Advancing Risk Stratification in Tricuspid Regurgitation: Incremental Prognostic Value of Effective RVEF on CMR

Performance of Atrial-fixation TMVR in Patients With Mitral Regurgitation (MR) and Mitral Annular Calcification (MAC)

Use of JenaValve in a Young Female With Severe Aortic Regurgitation and Takayasu Arteritis

Rare Case of Acute Severe Mitral Regurgitation Following Transcatheter Aortic Valve Implantation (TAVI)

Successful Acute Valve-in-Valve Implantation Using Evolut FX Transcatheter Valve in a Failed Non-Calcified Stentless Subcoronary Toronto (SJM) Valve With Severe Aortic Regurgitation

‘Sobering’ Adverse Event Rate With Evoque Seen in Real-world Use

Valve Thrombosis in TTVR Not Uncommon: Meta-analysis

Tendyne Approved in US for High-risk Patients With Mitral Valve Disease

Myval Noninferior to Other THVs at 1 Year, but Questions Persist

Procedural Volumes Matter for VT Ablation

BATMAN Signals New Way to Prevent LVOT Obstruction in High-Risk TMVR Patients

Pairing CIED Lead Extraction With Tricuspid Interventions Appears Safe

LuX-Valve TTVR Device Provides Favorable 1-Year Results

COMPARE-TAVI 1: Myval Performs Well Against Sapien at 1 Year

Aditya Mehta, MBBS

CMS Releases Proposed Decision Memo for Tricuspid TEER

By 2 Years, Tricuspid TEER Reduces Hospitalizations for HF: TRILUMINATE

Evolut Low Risk Trial: TAVI Holds Up to Surgery at 5 Years

More ALIGN-AR Data Bolster Potential for a Dedicated AR Device

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content